Is OKPRF or MRK a better dividend investment in 2026?

OKPRF currently yields 1333.33% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: OKPRF offers higher current income.

What is the dividend yield difference between OKPRF and MRK?

OKPRF has a forward dividend yield of 1333.33% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 1330.08 percentage points.

Home › Compare › OKPRF vs MRK

OKPRF vs MRK: Dividend Comparison 2026

OKPRF yields 1333.33% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 OKPRF wins by $241528700.58M in total portfolio value

INVESTMENT

TIME HORIZON10 years

OKPRF

● Live price

1333.33%

Share price

$0.15

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$241528700.61M

Annual income

$210,475,860,072,406.56

Full OKPRF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — OKPRF vs MRK

📍 OKPRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	OKPRF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, OKPRF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

OKPRF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OKPRF

Annual income on $10K today (after 15% tax)

$113,333.33/yr

After 10yr DRIP, annual income (after tax)

$178,904,481,061,545.56/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, OKPRF beats the other by $178,904,481,060,737.80/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OKPRF + MRK for your $10,000?

OKPRF: 50%MRK: 50%

100% MRK50/50100% OKPRF

Portfolio after 10yr

$120764350.32M

Annual income

$105,237,930,036,678.44/yr

Blended yield

87.14%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

OKPRF

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OKPRF buys

MRK buys

No recent congressional trades found for OKPRF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricOKPRFMRK

Forward yield	1333.33% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$241528700.61M ✓	$30.7K
Annual income after 10y	$210,475,860,072,406.56 ✓	$950.29
Total dividends collected	$239239876.27M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: OKPRF vs MRK ($10,000, DRIP)

Year	OKPRF Portfolio	OKPRF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$144,033	$133,333.33	$11,192	$351.54	+$132.8K → OKPRF
2	$1,948,924	$1,794,807.89	$12,524	$392.70	+$1.94M → OKPRF
3	$24,782,219	$22,696,870.86	$14,015	$438.65	+$24.77M → OKPRF
4	$296,245,945	$269,728,970.81	$15,682	$489.96	+$296.23M → OKPRF
5	$3,330,378,004	$3,013,394,842.54	$17,547	$547.23	+$3330.36M → OKPRF
6	$35,223,684,321	$31,660,179,856.69	$19,632	$611.16	+$35223.66M → OKPRF
7	$350,636,384,108	$312,947,041,885.16	$21,963	$682.53	+$350636.36M → OKPRF
8	$3,286,630,500,315	$2,911,449,569,318.85	$24,571	$762.18	+$3286630.48M → OKPRF
9	$29,021,346,295,663	$25,504,651,660,325.88	$27,486	$851.08	+$29021346.27M → OKPRF
10	$241,528,700,608,766	$210,475,860,072,406.56	$30,745	$950.29	+$241528700.58M → OKPRF

OKPRF vs MRK: Complete Analysis 2026

OKPRF — Stock

Okapi Resources Limited engages in the exploration and development of mineral properties in Australia and North America. The company explores for uranium and gold deposits. Its flagship project is the Tallahassee Uranium Project located in Colorado, the United States. The company was incorporated in 2017 and is based in Perth, Australia.

Full OKPRF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this OKPRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OKPRF vs SCHD OKPRF vs JEPI OKPRF vs O OKPRF vs KO OKPRF vs MAIN OKPRF vs JNJ OKPRF vs ABBV OKPRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.